Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSPIRE: Interferon gamma-1b in Idiopathic Pulmonary Fibrosis
NCT00075998Phase 3Terminated
- Sponsor
- InterMune
- Start
- Dec 2003
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in idiopathic pulmonary fibrosis (IPF) comparing Interferon gamma-1b with Placebo (2 arms). Primary endpoint: Survival time at 3.5 years. Started Dec 2003; status: terminated.
02
Drugs
interferon gamma-1b
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT00075998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075998.